Pyoderma Gangrenosum

As devoted clinicians to the field of wound management we take a responsibility to educate ourselves and others about wound etiologies and characteristics, as well as management of barriers to achieve...

Naltrexone is an opioid antagonist originally approved by the FDA in the early 1980s for the treatment of heroin addiction. The high dose of 50mg was used, but caused people to become too sick with wi...

Pyoderma gangrenosum can be a challenging diagnosis for providers to reach. In this video interview, Windy Cole, DPM, discusses how to rule out other diagnoses in order to arrive at a diagnosis of PG....

By Aletha Tippett MD Understanding Pathergy and Pyoderma Gangrenosum Pathergy is an aberration of the skin’s innate reactivity from a homeostatic reactive mode closely coupled to tissue healing to...

by Holly Hovan MSN, RN-BC, APRN, ACNS-BC, CWOCN-AP As discussed in a prior blog, stoma location is certainly one of the key factors in successful ostomy management and independence with care at hom...

By Temple University School of Podiatric Medicine Journal Review Club Editor's note: This post is part of the Temple University School of Podiatric Medicine (TUSPM) journal review club blog series...

By Aletha Tippett MD This month's blog is in response to a comment on Recognizing and Treating Wounds Caused by Pyoderma Gangrenosum: "What is green clay? Where do you get it? What does it do? Tha...

When I was in my APRN program, a phrase that I heard from an instructor has stuck with me throughout my practice: "When it comes to diagnosing, if you hear hooves, think horses, not zebras." Essential...